Trial Profile
A multicenter, double-blind, randomized, active controlled, parallel-group study to evaluate the efficacy, safety, tolerability and pharmacodynamic profiles of TL011 infusions compared with MabThera (rituximab) in subjects with severe, active rheumatoid arthritis treated with methotrexate (MTX)
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 09 May 2013
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ALTO
- 23 Jun 2012 Additional trial location (Netherlands) added as reported by European Clinical Trials Database.
- 26 May 2012 Additional locations added as reported by European Clinical Trials Database record.
- 24 May 2012 New trial record